Louisiana Attorney General Liz Murrill joined Mornings With Brian Haldane to discuss the escalating legal battle between LSU and the SEC, as well as a separate federal case involving access to abortion medication.
Murrill Challenges SEC Lawsuit Against LSU
Murrill said she believes the SEC lawsuit raises significant questions about the conference’s authority and its handling of athlete eligibility. The SEC amended its federal complaint to name Murrill in her official capacity after she filed an amicus brief supporting the athletes’ position in Louisiana state court.
The dispute centers on two athletes who had declared for the NFL draft and attended training camps, but were seeking to return to college competition under new eligibility rules. A Louisiana judge previously issued a preliminary injunction allowing them to pursue roster spots at LSU.
By the time of Murrill’s interview, however, LSU had finalized its 105-player roster without the players in question. That development changed the immediate eligibility dispute, although the broader legal fight continued.
Murrill argued that the controversy reflects a larger conflict over how NCAA and conference rules have changed and how those changes affect athletes who made career decisions based on earlier eligibility rules.
Murrill Heads to Court on Abortion Medication Case
Murrill also discussed her office’s challenge to federal rules governing access to mifepristone by mail. Her office argues that federal policy should require in-person dispensing and has challenged the FDA’s approach in federal court. The Fifth Circuit is considering the case.
The two cases illustrate the broad range of litigation facing the Louisiana Attorney General’s Office, from college athletics and state interests to federal regulation of abortion medication.